In women, it is much clearer that androgen excess is linked to the burden of CVD risk factors
insulin resistance is a consequence of androgen effects
Women with PCOS have a sustained exposure to high physiologic androgen levels. This condition is associated with endothelial dysfunction, obesity and metabolic abnormalities such as insulin resistance and dyslipidaemia
Further evidence of a link between high androgen levels and CVD or CVD risk factors is observed in women with polycystic ovary syndrome (PCOS)
For T treatment in aging women, the current data would suggest androgen excess has adverse effects on CVD risk factors, especially in women with diabetes
androgen use and abuse is increasing in our society, either for therapeutic or recreational reasons
For men, exogenous T treatment appears largely beneficial
I love these review articles that highlight the metabolic differences of hormones in women versus men. The medical community as a whole doesn't seem to get this at all. The marketing-based medical community doesn't either.
early study looking at saliva testing in infertility treatment. This goes back almost 33 years. But of course, it took medicine 176 years to recommend that Vitamin C help prevent scurvy on long sea journeys.
low ghrelin levels found in obese individuals (Pima Indians). Low ghrelin was associated with an inverse increase in fat, insulin, and leptin. It has also been shown to be associated with an inverse increase in Testosterone.
No significant statistical significance was found with vitamin D therapy and insulin sensitivity. However, improved outcomes were found in 2 hour insulin and 2 hour glucose levels after a 75 gram OGTT.
Chiro-inositol increases the action of insulin in patients with the polycystic ovary syndrome, thereby improving ovulatory function and decreasing serum androgen concentrations, blood pressure, and plasma triglyceride concentrations.
The metabolism of DCI is associated with insulin sensitivity and resistance, supporting the concept that second messengers have a role in responses to and resistance to insulin.
PET has been in use from quite a long time, but recent years showed a great surge in the demand worldwide. Easy availability of the PET material has great emphasis on packaging due to high-quality production with reduced costs. According to a forecast from Smithers Pira, there will be a sustained annual growth of 4.6 percent year-on-year basis in next five years. Other than established economies, transitional and emerging ones become prominent players in the marketplace.
Some of the testing procedures are as same as Pet bottle testing. However, glass bottles don't undergo bursting tests etc. If the quality manager wants to do the same, there are specially designed machines with closed cavities, to avoid any mishap when bottle bursts.